Curexo Inc. (KOSDAQ:060280)
South Korea
· Delayed Price · Currency is KRW 15,650
-540 (-3.34%)
Mar 9, 2026, 3:30 PM KST
Curexo Revenue
Curexo had revenue of 17.23B KRW in the quarter ending September 30, 2025, with 27.49% growth. This brings the company's revenue in the last twelve months to 27.85B, down -3.00% year-over-year. In the year 2015, Curexo had annual revenue of 27.53B with 5.33% growth.
Revenue (ttm)
27.85B
Revenue Growth
-3.00%
P/S Ratio
23.09
Revenue / Employee
960.27M
Employees
29
Market Cap
643.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2015 | 27.53B | 1.39B | 5.33% |
| Dec 31, 2014 | 26.14B | -4.95B | -15.93% |
| Dec 31, 2013 | 31.09B | 6.81B | 28.05% |
| Dec 31, 2012 | 24.28B | 13.74B | 130.32% |
| Dec 31, 2011 | 10.54B | -21.61B | -67.21% |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WON TECH | 147.26B |
| i-SENS | 313.10B |
| ToolGen | 1.07B |
| Seegene | 458.94B |
| InBody Co.,Ltd | 226.62B |
| Bio Plus | 96.80B |
| Seers Technology Co., LTD. | 11.42B |
| L&C BIO Co.,LTD | 79.99B |